PEGEX :

A patient can not avoid chemotherapy, as the first line of defense against cancer. However it increases chances of infection. For each chemotherapy cycle, it is important to be protected against such infections. Increasing neutrophils count (the infection fighter cells of our body) is one way to help protect against infections.

Pegex™ (Pegfilgrastim Injection) is prescribed to reduce the risk of infection in patients receiving chemotherapy. One injection of Pegex™ per chemotherapy cycle provides similar or better efficacy as 11 daily injections of Filgrastim.

The scientists of Gennova had developed Elaxim,indicated for acute myocardial infarction as the only biosimilar tenectaplase. With the launch of Pegex™, Gennova is fulfilling its mission of offering high quality and cost effective medicines made in India.